As a start, despite: limited number of schools; inadequate books; almost nonexistence of science laboratory; far distance students must travel to get to school; diversity of background of the population, especially urban and rural students, and not so high economic status of most of the families; it is a magic that a high proportion of the students succeeded. Hence, Debre Zeit has contributed more than its fair share of successful people like Dr. Tebabu Tessema Wubetu and his friends. Some of the high achievers are highlighted below:
Patents and Publications by Inventor Dr. Admassu Abebe
Dr Admassu Abebe is born in Debre Zeit. He attended elementary and High school in Deber Zeit. He completed his high school with Distinction in Debre Zeit in 1970. He attended Addis Abeba University and graduated from school of pharmacy with great distinction. He obtained his Masters degree from England and completed his P.H.D in Industrial Pharmacy from University of Grenoble, France. Dr. Admassu Abebe is a Senior Principal Scientist at Bristol-Myers Squibb based in New York City, New York.
Dr. Admassu Abebe’s Patents and Inventions
Patent number: 9616028b
Abstract: The present invention relates to bilayer tablet formulations comprising metformin extended release (XR) or reduced mass metformin XR formulation as the first layer, an SGLT2 inhibitor formulation as the second layer, and optionally a film coating. The present invention provides methods of preparing the bilayer tablet formulations and methods of treating diseases or disorders associated with SGLT2 activity employing the bilayer tablet formulations.
Type: Grant
Filed: May 7, 2015
Date of Patent: April 11, 2017
Assignees: AstraZeneca AB, AstraZeneca UK Limited
Inventors: Admassu Abebe, Kyle Martin, Jatin M. Patel, Divyakant Desai, Peter Timmins
Bilayer tablet formulations
Patent number: 9050258
Abstract: The present invention relates to bilayer tablet formulations comprising metformin extended release (XR) or reduced mass metformin XR formulation as the first layer, an SGLT2 inhibitor formulation as the second layer, and optionally a film coating. The present invention provides methods of preparing the bilayer tablet formulations and methods of treating diseases or disorders associated with SGLT2 activity employing the bilayer tablet formulations.
Type: Grant
Filed: August 13, 2013
Date of Patent: June 9, 2015
Assignee: AstraZeneca AB
Inventors: Admassu Abebe, Kyle Martin, Jatin M. Patel, Divyakant Desai, Peter Timmins
Bilayer tablet formulations
Patent number: 8535715
Abstract: The present invention relates to bilayer tablet formulations comprising metformin extended release (XR) or reduced mass metformin XR formulation as the first layer, an SGLT2 inhibitor formulation as the second layer, and optionally a film coating. The present invention provides methods of preparing the bilayer tablet formulations and methods of treating diseases or disorders associated with SGLT2 activity employing the bilayer tablet formulations.
Type: Grant
Filed: November 12, 2010
Date of Patent: September 17, 2013
Assignees: Bristol-Myers Squibb Company, AstraZeneca UK Limited
Inventors: Admassu Abebe, Kyle Martin, Jatin M. Patel, Divyakant Desai, Peter Timmins
Dr. Admassu Abebe’s research Publications:
Dr. Admassu Abebe’s research while affiliated with Bristol-Myers Squibb and other places.
Number of Publications: 21
Few Examples:
Evolution of the microstructure during the process of consolidation and bonding in soft granular solids
Article
Feb 2016
Bereket Yohannes, Gonzalez, Abebe[…], Alberto M Cuitiño
The evolution of microstructure during powder compaction process was investigated using a discrete particle modeling, which accounts for particle size distribution and material properties, such as plasticity, elasticity, and inter-particle bonding. The material properties were calibrated based on powder compaction experiments and validated based on…
The role of fine particles on compaction and tensile strength of pharmaceutical powders
Article
Apr 2015
Bereket Yohannes, Gonzalez, Abebe[…], Alberto M Cuitiño
The role of fine particles on compaction of powders and the resultant compact was studied experimentally. Samples of powders were prepared by successively removing fine particles from microcrystalline cellulose and lactose monohydrate powders. This method of preparing samples is unique compared to previous studies on particle size distribution, and…
Review of Bilayer Tablet Technology.
Article
Dec 2013
Admassu Abebe, Ilgaz Akseli, Omar Sprockel[…], Alberto M Cuitiño
Therapeutic strategies based on oral delivery of bilayer (and multilayer) tablets is gaining more acceptance among brand and generic products due to a confluence of factors including advanced delivery strategies, patient compliance and combination therapy. Successful manufacturing of these ever more complex systems needs to overcome a series of cha…
Axial strength test for round flat faced versus capsule shaped bilayer tablets
Article
Nov 2013
Jason Franck, Admassu Abebe, Rekha Keluskar[…], Howard Stamato
Abstract There has been increasing interest in fixed dose combination (FDC) therapy. Multi-layer tablets are a popular choice among various technologies to deliver FDCs. In most cases, round flat faced tooling is used in testing tablets as they have the simplest geometry. However, shaped tooling is more common for commercial products and may have a…
The Use of Foam in High Shear Wet Granulation: Effect of Scale up On Granules Quality Attributes
Conference Paper
Nov 2010
Niranjan Kottala, Admassu Abebe, Faranak Nikfar[…], Robert Jerzewski
High shear wet granulation is a common pharmaceutical unit operation for forming agglomerates. The API under study offered challenges during processing due to its low bulk density, low particle size, and its adhesive nature when in contact with water. To address the above challenges a new granulation process was employed whereby liquid binders are…
Patents by Inventor Dr. Taddesse Gebregiorgis




